Fig. 1From: Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES IIIUnadjusted Kaplan-Meier survival curves for all-cause mortality by IgA anti-tTG antibodies status in the National Health and Nutrition Examination Survey (NHANES) III from 1988 to 2006. Overall survival for all subjects (a), males (b), and females (c) with elevated IgA anti-tTG antibodies vs. IgA anti-tTG negative individualsBack to article page